Under construction – not a live service
Sign in
Taking people in NetherlandsNo phase

Studying hand function problems in people with systemic sclerosis

Follows people with systemic sclerosis to study causes of hand function loss over time.

Plain-language title generated from the registry record
Registry title: Hand Function Impairment in Systemic Sclerosis: Outcomes, Mechanisms and Experience (HANDSOME)

Key facts

Where
Utrecht, NetherlandsSee the site

Where in Netherlands

  • UMC UtrechtUtrecht, NetherlandsTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
UMC Utrecht
Trial code
NCT06133244
Record updated
28 May 2024
Original description
Almost 90% of systemic sclerosis (SSc) patients experience hand function limitation, which leads to impaired daily functioning and work participation. An important cause of impaired hand function are contractures of the hand, which are reported in up to a half of patients. With this longitudinal cohort study in patients with SSc and VEDOSS (very early diagnosis of systemic sclerosis) the investigators aim to gain more insight into processes involved in hand function impairment.Read full original descriptionShow less

Hand Function Impairment in Systemic Sclerosis: Outcomes, Mechanisms and Experience (HANDSOME) Study

Almost 90% of systemic sclerosis (SSc) patients experience hand function limitation, which leads to impaired daily functioning and work participation. An important cause of impaired hand function are contractures of the hand, which are reported in up to a half of patients. With this longitudinal cohort study in patients with SSc and VEDOSS (very early diagnosis of systemic sclerosis) the investigators aim to gain more insight into processes involved in hand function impairment.

Inclusion: Age > 18 years.

Exclusion: Patients with diabetic cheiroarthropathy and Dupuytren's disease, based on expert opinion.

ClinicalTrials.gov NCT06133244